← Open Payments lookup

RACHEL CLARK: Open Payments

NPI 1255728648 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,810 in 89 payments from 21 companies in 2025. Trend: 2023 $591 · 2024 $1,807 · 2025 $1,810

Food & beverage: $1,710Education: $100
CompanyPaymentsAmount
ABBVIE INC.13$235
Teva Pharmaceuticals USA, Inc.10$225
Lundbeck LLC14$212
E.R. Squibb & Sons, L.L.C.9$172
Alkermes, Inc.7$153
Otsuka America Pharmaceutical, Inc.7$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$123
Vanda Pharmaceuticals Inc.4$108
Neurocrine BioSciences, Inc.4$84
Axsome Therapeutics, Inc.2$48

Products named: COBENFY, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, ARISTADA, CAPLYTA, INGREZZA, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.